AzTrials
AzTrials

CompulsionRECONNCT03989765

Reducing Coercion in Norway (RECON)

A study testing Programme to reduce involuntary treatment episodes in people with Compulsion, run by University Hospital, Akershus at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is considerable geographical variation in the rates of compulsion in psychiatric services within as well as between countries. Reducing the use of compulsion of patients with severe mental illness is an expressed policy aim, and also a demand from service user organisations. Read more about this study

Who is it for?
Any age
Conditions the study is for
Compulsion
What is being tested?
Programme to reduce involuntary treatment episodes
Could I receive a placebo?
No, everyone receives an active treatment
How many people
900 participants
Where
1 siteNorway
Study dates
25 Jun 2019to 30 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • Municipalities neighbouring another eligible municipality will not be included to prevent contamination should one of them be randomised to the intervention group. The municipality with the lowest rate of involuntary treatment episodes will be removed

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Akershus University Hospital

    Lørenskog, 1478

Other trials in Norway

About this study

Official title: How Can We Reduce The Use Of Compulsion Of People With Severe Mental Illness

There is considerable geographical variation in the rates of compulsion in psychiatric services within as well as between countries. Reducing the use of compulsion of patients with severe mental illness is an expressed policy aim, and also a demand from service user organisations. In Norway, municipalities hold responsibility for primary care and are therefore central to the delivery of services to people with severe mental illness. This indicates a potential for intervening at the municipal level to reduce the use of compulsion where it is high. The Reducing Coercion in Norway study (RECON) will, in collaboration with municipalities with high compulsion rates, develop a municipal-level intervention (Stage 1) that will be implemented in a cluster-RCT (Stage 2) to test if it has effect on compulsion rates.pulsion rates.

Read the detailed description

BACKGROUND:

In Norway, as in other parts of the Western world, there have been concerns about increase in the use of compulsory mental health care for patients with severe mental illness. There is growing public concern, however, despite the explicit instruction from the Norwegian government that health services should reduce the use of compulsion, rates have not decreased. The Reducing Coercion in Norway study (RECON) is designed to develop and test an intervention, at the municipal level, to reduce the use of compulsion.

Most referrals to compulsory treatment come from primary care. In Norway, it is the 400+ municipalities who hold responsibility for primary care. This includes multi-disciplinary municipal mental health teams, substance abuse services, social care and GP services. At the Specialist level, four Regional Health Authorities Commission a number of Health Trusts to deliver specialist mental health care through acute hospitals and District Psychiatric Centres. These centres often collaborate, in different ways, with municipal services.

Municipal service providers are often those in most frequent contact with patients with severe mental illness, and will commonly be those detecting early signs of relapse. Importantly, municipal services (usually GPs or out of hours emergency services) will serve as gatekeepers for involuntary admissions, as they refer to specialist services who then may invoke the Mental Health Act that sanctions compulsion. This suggests a potential for developing strategies within municipal services to intervene early and possibly prevent some episodes of compulsion. Very little research has investigated the role municipal services play in the compulsion or on relevant cross-sectoral collaborations. There is also limited research on out-patient interventions designed to reduce compulsion. A systematic review could only include 15 experimental studies internationally. Joint crisis plans, risk assessments and counselling of staff were identified as promising interventions. However, most studies had insufficient samples or were of too poor quality to draw conclusions. Moreover, all included studies were based in specialist out-patient services.

The 'Six Core Strategies' intervention, developed to reduce seclusion and restraint in psychiatric hospitals, has shown positive effects. The six strategies involved are: structured efforts to improve leadership and organisational change; use of data to inform practice; workforce development; use of seclusion and restraint reduction tools; involvement of peers, and; rigorous debriefing techniques. It has been implemented in six countries, with positive results. No equivalent has been developed for municipal services. Service users and clinicians in Norway have, however, suggested potential strategies for municipal services to impact on compulsion rates. These include crisis plans; structured meetings of patients' networks, spaces for informal contact; key contact persons for patients; improved skills for early detection of relapse and; improved local collaboration. Given the potential role of municipalities for reducing the use of compulsion, it seems clear that further research is needed. RECON takes the Six Core Strategies model as a starting point for developing and testing a municipality-based intervention for reducing the use of compulsion.

AIM To develop, implement and test the effectiveness of a municipality-based intervention to reduce the use of compulsion in mental health services, in municipalities with rates of involuntary treatment episodes above the national average.

The aim will be reached through a two-staged approach.

OBJECTIVES AND METHODS STAGE 1:

In order to facilitate stakeholder input and to ground the research in a thorough understanding of the structures and processes of municipal service delivery, much of the data to address Objectives 1-3 will be collected through a mix of qualitative methods.

  1. To identify and secure the participation of mid-sized municipalities with above average levels of involuntary treatment episodes Mid-sized municipalities (20-50K inhabitants), with above average rates of compulsion and motivated to change service delivery to tackle compulsion, will be recruited to take part in the study. This will take place in the period June- September 2019.
  2. To map the mechanics of current practice together with local health and social services, service users, family caregivers and other stakeholders Local current practice will be mapped regarding what services are available in the intervention sites and how they work individually and collaboratively with patients with severe mental illness. Particular focus will be on the processes in municipal services that lead to involvement of GPs and possible referral for assessment for compulsion, and how patients are cared for after discharge (some of them subject to outpatient compulsion). Across the five sites semi-structured interviews and/or focus groups will be conducted with service leads in municipal mental health and addiction services (outpatient and housing services), GPs, social services and corresponding services in the local DPCs and focus groups with service users and family caregivers. These data will be subject to thematic analysis. Content analyses will be conducted of relevant service plans and other documents outlining leadership and workforce development, service collaboration, and any relevant guidelines. This will take place in the period July- December 2019.
  3. To develop a municipality-based intervention for reducing compulsion in collaboration with municipalities and service users. The data collected will be used in the development of the intervention through mediated dialogue seminars with services in the intervention sites. Based on the Six Core Strategies it is likely that themes will include: leadership and organizational change; using data to inform practice; workforce development; use of seclusion and restraint reduction tools (in the municipal setting this might include crisis plans, risk assessment and de-escalation tools); involve peers, and; rigorous debriefing techniques (most likely after a referral for assessment for detention and/or after discharge from hospital). This will take place in the period January- March 2020. OBJECTIVES AND METHODS, STAGE 2:
  4. To implement and study the intervention in five municipalities The intervention developed in Stage 1 will be implemented by services in five municipalities, supported by the research team. Regular site visits and contacts will be conducted to monitor progress and fidelity to the intervention in the intervention sites. This will feed into a process evaluation that will identify potential facilitating factors and barriers for successful implementation. This will take place in the period April 2020- April 2021.
  5. To test the effect of the intervention in a cluster-randomised controlled trial The effectiveness of the intervention will be measured by comparing the change in outcomes between the intervention and the control group (difference in difference). Outcome data will be obtained aggregated at municipality level, from the National Patient Registry and be measured over three time periods.

The main hypotheses are that:

  • There will be a larger reduction in prevalence rate of involuntary treatment episodes in the intervention arm as compared with the control arm during the intervention period (i.e., Index vs T1) (primary analysis)
  • There will be a larger reduction in prevalence rate of involuntary treatment episodes in the intervention arm as compared with the control arm in the longer term (i.e., Index vs T2).

The investigators similarly hypothesise that the change in secondary outcomes will be larger in the intervention arm than the control arm during the intervention period (i.e., Index vs T1) and in the longer term (i.e., Index vs T2)

SAMPLE SIZE CONSIDERATIONS Asking municipalities to take part in a research programme by which they are required to change current practices is likely to be experienced as demanding. As explained above, research staff will be supporting the municipalities throughout. It is therefore necessary to keep the number of clusters at a manageable size.

Because outcome data will be aggregated at municipality level, power calculation at patient level is precluded. Based on current statistics, a mid-sized municipality has 40-100 involuntary admissions and 12-30 episodes of outpatient compulsion each year. Municipalities with above average rates of compulsory treatment per 10K population will be targeted, with the aim to include five municipalities in the intervention arm and five in the control arm. This should be sufficient to give stable estimates of the primary and secondary outcome measures.

STATISTICAL ANALYSES Prevalence rates in the intervention and the control arms during the Index, T1 and T2 periods will be calculated and presented together with 95% confidence intervals. Differences between the intervention and the control arm in the change in prevalence rate from the Index to the T1 period (as primary analysis) and the Index to the T2 period will be assessed by z-test for proportions. Change in overall duration of involuntary treatment episodes will be compared between the intervention and the control arm by Independent samples t-test. Even though the available data will be aggregated at municipality level, knowing the size of each municipality, the number of episodes, mean length of episodes and standard deviation for those length of episodes will enable the use of the aforementioned tests. Exploratory analyses comparing outcomes between T1 and T2 periods will be considered.

CONSENT

  • In each cluster, consent to participate will be obtained from the person in charge of municipal mental health services
  • All professionals, patients and family carers who participate in qualitative research activities in Stage 1will provide individual informed consent prior to enrolment
  • All primary and secondary outcome measures will be collected from the Norwegian Patient Records and will be aggregated at municipal level. As no research activity will take place in control sites, no consent will be sought.

RANDOMISATION:

Randomisation of eligible municipalities took place prior to inviting interventions municipalities to take part as follows. All municipalities that met the inclusion criteria (n=28) were ranked in descending order of the rates of involuntary admission per 10K population. In the cases where two or more neighbouring municipalities were on that list (n=7), the ones with the lowest rate were excluded. This left a list of 21municipalities. Paired stratification was applied by which paired the first and second municipality on the list were paired, number 3 and 4, number 5 and 6 etc. Within each pair, one municipality was drawn at random to take part in the intervention arm and the other was allocated to the control arm. If a municipality allocated to the intervention arm declines to take part, the control municipality will not be included. It was important to avoid a large spread in terms of the rate of involuntary admissions. Therefore, if a municipality allocated to the intervention arm declines participation and their neighbouring municipality had been excluded, that neighbour municipality will no longer be ineligible and will be included in the intervention arm, if willing to participate.

Conditions
Compulsion
Being tested
Programme to reduce involuntary treatment episodes
Medical subject headings
Compulsive Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Programme to reduce involuntary treatment episodesOther

    Also called Treatment as usual

    See description of trial arms

Study groups in NCT03989765
Study groupRoleWhat they receive
Intervention armExperimentalMunicipalities in the intervention arm will, in Stage 1, be part of developing the intervention to reduce the rate of compulsion. In Stage 2 they will implement the intervention through their services.
Receives: Other: Programme to reduce involuntary treatment episodes
Control municipalityNo interventionAs all outcome measures will be collected from the National Patient Register, there will be treatment as usual.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in prevalence rates of involuntary treatment episodes

    Change in prevalence rates of involuntary treatment episodes per 10K inhabitants over the age of 18. Involuntary treatment episodes will include both inpatient and outpatient episodes of compulsion

    Measured: 12 months prior to and 12 months during the intervention

  2. Change in prevalence rates of involuntary treatment episodes

    Change in prevalence rates of involuntary treatment episodes per 10K inhabitants over the age of 18. Involuntary treatment episodes will include both inpatient and outpatient episodes of compulsion

    Measured: 12 months prior to and 12 months after the intervention period has ended

Secondary outcomes (3)
  1. Referral rates

    Change in prevalence rates of referral for compulsion per 10K population >18 years

    Measured: 12 months prior to and 12 months during the intervention

  2. Referral outcome

    Change in prevalence rates of referral outcome (compulsory vs voluntary status)

    Measured: 12 months prior to and 12 months during the intervention

  3. Duration of compulsion

    The duration of all involuntary treatment episodes (calculated from number of episodes, mean length of episodes and SD for length of episodes)

    Measured: 12 months prior to and 12 months during the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2019
  2. Study start25 Jun 2019
  3. Primary completion30 Sep 2022
  4. Study completion30 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Cluster randomised controlled trial. 5 clusters per study arm
Masking
None (open label)
Enrolment
900 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03989765
Sponsor's protocol ID
298907
Other IDs
273546
Acronym
RECON
Status last verified
Jun 2024
First submitted
6 Jun 2019
Last updated
5 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Not applicable. No individual patient date will be collected.

Publications

  • Rugkasa J, Nyttingnes O, Saltyte Benth J, Husum TL, Kjus SHH, Wormdahl I, Hofstad T, Hatling T. Can primary mental health services impact levels of involuntary admissions? A cluster-RCT of the ReCoN intervention. Soc Psychiatry Psychiatr Epidemiol. 2025 Sep;60(9):2077-2087. doi: 10.1007/s00127-025-02914-3. Epub 2025 Apr 30.

    PubMed 40307589

Questions about this trial

What is this clinical trial studying?

A study testing Programme to reduce involuntary treatment episodes in people with Compulsion, run by University Hospital, Akershus at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in prevalence rates of involuntary treatment episodes (time frame: 12 months prior to and 12 months during the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03989765, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in